Monsoon illnesses and a significant rise in H1N1 cases are driving a surge in demand for acute therapies and flu vaccines. Sales of anti-infectives and antibacterials saw a 12% month-on-month increase in July, with flu vaccine sales nearly tripling year-on-year in August, leading to supply challenges in several cities.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Ak4YGcN
via IFTTT
-
Lilly's Mounjaro has rapidly become the second-highest selling drug in India's pharmaceutical market, achieving ₹233 crore in sales ...
-
India's Syngene International has agreed to acquire its first biologics facility in the U.S. from Emergent Manufacturing for $36.5 milli...
-
The Indian Council of Medical Research has licensed three new biomedical technologies. These innovations aim to advance cancer treatment and...
Search This Blog
Powered by Blogger.
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment